Summary of Changes

Attachment C
Paperwork Reduction Act Submission
OMB # 0938 – 0944
CMS-10142
Summary of Changes
The following revisions are in response to Lessons Learned feedback (from industry, contracted
bid reviewers and internal CMS) and contract year 2023 effective provisions of the Medicare
Advantage and Prescription Drug Program. They do not result in a change to the estimated
burden.
1) Updated labels/parameters: Annual update of labels/parameters (ex: CY2022 → CY2023).
Locations: PD Worksheet 1 cell N3, F5, C29:C31, B43
PD Worksheet 7 cell B9, C10:C12
MA Worksheet 1 cell Q3, D8
MA Worksheet 6 cell E14
MSA Worksheet 1 cell P3, D8
MSA Worksheet 4 cell H48, H53
ESRD-SNP Worksheet 1 cell B6, C1, I2, I3
ESRD-SNP Worksheet 2 cell E16:E19
Reason: Update BPT to reference Contract Year 2023 information.
2) Removed insurer fee input cells from MA, ESRD-SNP and PD BPT
Locations: MA Worksheet 1 cells H60:K60
ESRD-SNP Worksheet 3 cells A59, G59
PD Worksheet 1 cells B52:G52
Reason: To improve accuracy/clarity of BPT for CY2023.
3) Removed corporate margin cells from MA and PD BPT.
Locations: MA Worksheet 4 cells J100:M102
ESRD-SNP Worksheet 2 cells E43:G45
PD Worksheet 3 B46:D48
Reason: To improve accuracy/clarity of BPT for CY2023.
4) Revised Bid Instruction language to be consistent with proposed changes to BPTs listed above
and presented on November 2021 Fall Actuarial User Group Call.
Reason: To improve accuracy/clarity of BPT Instructions for CY2023.

Page 1 of 1